Argireline vs Matrixyl

Argireline mimics part of SNAP-25 to reduce muscle-contraction signalling — a topical "Botox-like" concept. Matrixyl is a matrikine peptide that signals fibroblasts to produce collagen.

HPLC tested · JanoshikJanoshik CertificatesNationwide DeliveryResearch Only

🧪

Argireline

A synthetic hexapeptide patterned on the N-terminus of SNAP-25, studied as a topical "Botox-like" anti-wrinkle ingredient.

BEST STUDIED FOR

Skin peptides

Read the cited profile →

🧪

Matrixyl

A lipidated fragment of type I pro-collagen (Lys-Thr-Thr-Lys-Ser) used as a topical "signal peptide" to stimulate matrix production.

BEST STUDIED FOR

Skin peptides

Read the cited profile →

SIDE BY SIDE

	Argireline	Matrixyl
The key difference	Acetyl hexapeptide-3 — SNARE inhibition	Palmitoyl pentapeptide-4 — collagen signal
Class	Skin peptides	Skin peptides
Mechanism	Argireline competes with SNAP-25 for a place in the SNARE complex, the protein machinery that releases neurotransmitter at the neuromuscular junction.	KTTKS is a pro-collagen subfragment reported to feed back on fibroblasts to increase collagen and other matrix components; the palmitoyl chain improves skin penetration and stability.
Status	A widely used cosmetic ingredient with several small clinical studies; skin penetration is a recognised limitation.	Cosmetic ingredient with small clinical studies and in-vitro work; delivery systems remain an active topic.
Reported safety signals	Topical studies report it as well tolerated; it is far less potent than botulinum toxin, which is the safety rationale for its design.	Topical studies report good tolerability.
A key study	Describes Argireline’s design as a SNARE-complex-inhibiting peptide and its anti-wrinkle activity. (Int J Cosmet Sci 2002, PMID 18498523)	A clinical study measured changes in photoaged facial skin with topical pal-KTTKS. (Int J Cosmet Sci 2005, PMID 18492182)

WHEN TO RESEARCH WHICH

Argireline for expression-line research; Matrixyl for matrix-remodelling research. Both are discussed here strictly as research compounds; nothing on this page is medical advice or a dosing guide.

REFERENCES (PUBMED)

[Argireline] A synthetic hexapeptide (Argireline) with antiwrinkle activity — Int J Cosmet Sci 2002. PMID 18498523
[Argireline] The anti-wrinkle efficacy of Argireline — J Cosmet Laser Ther 2013. PMID 23464592
[Argireline] Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow’s Feet — J Clin Aesthet Dermatol 2023. PMID 36909866
[Matrixyl] Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin — Int J Cosmet Sci 2005. PMID 18492182
[Matrixyl] Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS) — Biomol Ther (Seoul) 2014. PMID 25143811
[Matrixyl] Effect of Palmitoyl-Pentapeptide (Pal-KTTKS) on Wound Contractile Process in Relation with Connective Tissue Growth Factor and α-Smooth Muscle Actin Expression — Tissue Eng Regen Med 2017. PMID 30603464

FREQUENTLY ASKED

What is the difference between Argireline and Matrixyl?

Argireline mimics part of SNAP-25 to reduce muscle-contraction signalling — a topical "Botox-like" concept. Matrixyl is a matrikine peptide that signals fibroblasts to produce collagen.

What is the regulatory status of Argireline and Matrixyl?

Argireline: A widely used cosmetic ingredient with several small clinical studies; skin penetration is a recognised limitation. Matrixyl: Cosmetic ingredient with small clinical studies and in-vitro work; delivery systems remain an active topic.

What safety signals have been reported?

Argireline: Topical studies report it as well tolerated; it is far less potent than botulinum toxin, which is the safety rationale for its design. Matrixyl: Topical studies report good tolerability.

Which studies is this comparison based on?

For Argireline: “A synthetic hexapeptide (Argireline) with antiwrinkle activity” (PMID 18498523); “The anti-wrinkle efficacy of Argireline” (PMID 23464592); “Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow’s Feet” (PMID 36909866). For Matrixyl: “Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin” (PMID 18492182); “Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS)” (PMID 25143811); “Effect of Palmitoyl-Pentapeptide (Pal-KTTKS) on Wound Contractile Process in Relation with Connective Tissue Growth Factor and α-Smooth Muscle Actin Expression” (PMID 30603464).